NCT05278520 Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
| NCT ID | NCT05278520 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Turku |
| Condition | Osteoarthritis, Hip |
| Study Type | OBSERVATIONAL |
| Enrollment | 110 participants |
| Start Date | 2023-01-11 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 110 participants in total. It began in 2023-01-11 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.
Eligibility Criteria
Inclusion Criteria for the main (OA) study: Cases: Adult patients with osteoarthritis in the hip joint and who are going through an elective total hip arthroplasty. Controls: Non-arthritis adult patients who are going through a trauma-based emergency total hip arthroplasty. \---- Inclusion Criteria for the Rheumatoid sub-study: Adult patients with rheumatoid arthritis in the hip joint and who are going through an elective total hip arthroplasty. \---- Exclusion Criteria: * The body mass index must be below 35 * Age \< 18 or \> 74 * The OA patients may not have diabetes, rheumatoid arthritis (RA), or metabolic syndrome. For the Rheumatoid sub-study, the exclusion criteria are the same as above except for the RA.
Contact & Investigator
Lea Mikkola, PhD
PRINCIPAL INVESTIGATOR
Turku Bioscience, University of Turku
Frequently Asked Questions
Who can join the NCT05278520 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 74 Years, studying Osteoarthritis, Hip. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05278520 currently recruiting?
Yes, NCT05278520 is actively recruiting participants. Contact the research team at limikk@utu.fi for enrollment information.
Where is the NCT05278520 trial being conducted?
This trial is being conducted at Turku, Finland, Turku, Finland, Turku, Finland, Espoo, Finland.
Who is sponsoring the NCT05278520 clinical trial?
NCT05278520 is sponsored by University of Turku. The principal investigator is Lea Mikkola, PhD at Turku Bioscience, University of Turku. The trial plans to enroll 110 participants.